express科学加速器 安卓

express科学加速器 安卓

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

express科学加速器 安卓

Learn More
Folded page of a newspaper

express科学加速器 安卓

express科学加速器 安卓

Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results

express科学加速器 安卓

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

express科学加速器 安卓

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

express科学加速器 安卓

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

express科学加速器 安卓

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

express科学加速器 安卓

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

手机翻国外网站教程  Sgreen加速器官网  上老王论坛当老王链接  小草破解版app  黑洞加速器下载安卓  快连加速器app下载  Zero加速器官网